NCT07296146
Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 10 words Show 6 more changesShow less
- Completed without a posted recruiting period
- Primary completion date changed from estimate of Mar 15, 2026 to Aug 1, 2026
- Study sites: 0 to 1
- Study completion date changed from estimate of May 15, 2026 to Aug 15, 2026
- Start date changed from estimate of Dec 15, 2025 to Feb 1, 2026
- Secondary endpoints revised (2)
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
- Hemoglobin concentration
Timeframe: at baseline, and 3-months postintervention
- Erythropoietin resistance index (ERI)
Timeframe: at baseline, and 3-months postintervention
Secondary (2)
Serum creatine
Urea Reduction Ratio
Arms and interventions
EPO + ProbioticActive comparator
EPO (4000 IU) + Probiotic
EPOActive comparator
Erythropoietin (Epoetin 4000 IU)
Drugs: Erythropoietin + Probiotic, EPO
Sites
1 site in 1 country
- Badr University HospitalCairo, Dr, Egypt